Alzheimer Disease Patients Who Survived COVID-19 Have Rapid Disease Progression and a Higher Risk of Death at 5-year Follow-up
These findings suggest that SARS-CoV-2 infection may accelerate AD progression and reduce survival, particularly in cases requiring hospitalization. Future multicenter studies with large sample sizes are needed to confirm these findings.
Authors
- Karen Barros Parron Fernandes (ORCID: https://orcid.org/0000-0002-1276-4900)
- Márcia Chaves da Silva (ORCID: https://orcid.org/0000-0002-1348-9875)
- Paulo Roberto Bignardi (ORCID: https://orcid.org/0000-0002-4730-0946)
- Lindsey Mitie Nakakogue (ORCID: https://orcid.org/0000-0003-4571-7120)
- Giulia Zaparoli Ursi
Institutions
- Pontifícia Universidade Católica do Paraná (BR)
Publication Details
- Journal
- Alzheimer Disease & Associated Disorders
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1097/wad.0000000000000700
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00